A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting

New England Journal of Medicine

Volumn 339, Issue 23, 1998, Pages 1665-1671

  Leon, Martin B ^a   Baim, Donald S ^b   Popma, Jeffrey J ^a   Gordon, Paul C ^c   Cutlip, Donald E ^b   Ho, Kalon K L ^b   Giambartolomei, Alex ^d   Diver, Daniel J ^e   Lasorda, David M ^f   Williams, David O ^g   Pocock, Stuart J ^h   Kuntz, Richard E ^b  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c MIRIAM HOSPITAL   (United States)

^d St Joseph's Hospital   (United States)

^e GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^f ALLEGHENY GENERAL HOSPITAL   (United States)

^g RHODE ISLAND HOSPITAL   (United States)

^h LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CREATINE KINASE MB; HEPARIN; TICLOPIDINE; WARFARIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DEATH; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA; THROMBOSIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; ASPIRIN; CORONARY DISEASE; DRUG THERAPY, COMBINATION; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; SINGLE-BLIND METHOD; STENTS; THROMBOSIS; TICLOPIDINE; WARFARIN;

EID: 0032481092     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199812033392303     Document Type: Article

References (18)

1. Serruys PW, Strauss BH, Beatt KJ, et al. Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med 1991; 321:13-7.
2. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
3. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-95.
4. Macaya C, Serruys PW, Ruygrok P, et al. Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial: Benestent Study Group. J Am Coll Cardiol 1996;27:255-61.
5. Cohen DJ, Krumholz HM, Sukin CA, et al. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty: results from a randomized clinical trial: Stent Restenosis Study Investigators. Circulation 1995;92:2480-7.
6. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995;91:1676-88.
7. Serruys PW, Emanuelsson H, van der Giessen W, et al. Heparin-coated Palmaz-Schatz stents in human coronary arteries: early outcome of the Benestent-II Pilot Study. Circulation 1996;93:412-22.
8. Bairn DS, Carrozza JP Jr. Stent thrombosis: closing in on the best preventive treatment. Circulation 1997;95:1098-100.
9. Schömig A, Neumann F-J, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stems. N Engl J Med 1996;334:1084-9.
10. Mass WK, Easton JD, Adams HP Jr, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989;321:501-7.
11. Albiero R, Hall P, Itoh A, et al. Results of a consecutive series of patients receiving only antiplatelet therapy after optimized Stent implantation: comparison of aspirin alone versus combined ticlopidine and aspirin therapy. Circulation 1997;95:1145-56.
12. Hall P, Nakamura S, Maiello L, et al. A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation 1996;93:215-22.
13. Blackwelder WC. "Proving the null hypothesis" in clinical trials. Control Clin Trials 1982;3:345-53.
14. The logistic procedure. In: SAS/STAT user's guide, version 6. Vol. 2. Cary, N.C.: SAS Institute, 1990:1071-134.
15. Morice MC, Zemour G, Benveniste H, et al. Intracoronary stenting without Coumadin: one month results of French multicenter study. Cathet Cardiovasc Diagn 1995;35:1-7.
16. Karrillon GJ, Morice MC, Benveniste E, et al. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy: 30-day clinical outcome of the French Multicenter Registry. Circulation 1996;94:1519-27.
17. Bennett CL, Weinberg PD, Rozenberg-Ben-Dror K, Yarnold RR, Kwaan HC, Green D. Thrombotic thrombocytopenic purpura associated with ticlopidine: a review of 60 cases. Ann Intern Med 1998;128:541-4.
18. Bennett CL, Kiss JE, Weinberg PD, et al. Thrombotic thrombocytopenic purpura after stenting and ticlopidine. Lancet 1998;352:1036-7.